EASCRA THERAPEUTICS
Dead / Abandoned — Abandoned — failure to respond (as of 09 May 2024)
What this means for you
This application is over — abandoned 25 Apr 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97074117
- Mark type
- Stylized text
- Filed
- 14 Oct 2021
- Published for opposition
- 07 Feb 2023
- Abandoned
- 25 Apr 2024
- Attorney of record
- Alan Feeney
Goods and services
- Class 010 — Medical apparatus: Delivery systems for medicinal therapeutics, namely, Janus Base nanotubes; delivery systems for medicinal therapeutics, namely, mRNA nanotubes; medicinal therapeutics delivery systems for the treatment of diseases, namely, Janus Base nanotubes; medicinal therapeutics delivery systems for the treatment of cancers and neurological conditions, namely, Janus Base nanotubes; medicinal therapeutics delivery systems for the treatment of neurological conditions, namely, neurodegenerative diseases, namely, Janus Base nanotubes
Owner
- EASCRA BIOTECH INC, BOSTON, MA, US
- EASCRA BIOTECH INC, BOSTON, MA, US
- Mari Anne Snow, Providence, RI, US
Prosecution history
- 09 May 2024 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 09 May 2024 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 24 Jan 2024 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 24 Jan 2024 — FINAL REFUSAL E-MAILED
- 24 Jan 2024 — SU - FINAL REFUSAL - WRITTEN
- 19 Jan 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 19 Jan 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 Jan 2024 — ASSIGNED TO LIE
- 29 Aug 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 31 May 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 May 2023 — NON-FINAL ACTION E-MAILED
- 31 May 2023 — SU - NON-FINAL ACTION - WRITTEN
- 16 May 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Apr 2023 — USE AMENDMENT FILED
- 01 May 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL